HIGHLIGHTS
- What: This study focuses on the EGFR, seeks to identify novel compounds with strong therapeutic potential.
- Who: Abdullah R. Alanzi et al. from the Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia have published the article: Integration of pharmacophore-based virtual screening, molecular docking, ADMET analysis, and MD simulation for targeting EGFR: A comprehensive drug discovery study using commercial databases, in the Journal: PLOS ONE
- How: The authors developed a ligand-based pharmacophore model using the chemical features of a co-crystal ligand (R85) of Epidermal growth factor receptor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.